We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+8.21%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$214M
AUM Growth
+$9.71M
Cap. Flow
-$616K
Cap. Flow %
-0.29%
Top 10 Hldgs %
6.68%
Holding
490
New
42
Increased
186
Reduced
165
Closed
36

Top Buys

Rank Stock Value
1
OCCI
OFS Credit Co
OCCI
+$2.05M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$1.92M
3
ECC
Eagle Point Credit Company
ECC
+$1.26M
4
APP icon
Applovin
APP
+$1.04M
5
CEG icon
Constellation Energy
CEG
+$1.01M

Top Sells

Rank Stock Value
1
OXLC
Oxford Lane Capital
OXLC
+$1.49M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.06M
3
GEN icon
Gen Digital
GEN
+$1.01M
4
ADBE icon
Adobe
ADBE
+$989K
5
STE icon
Steris
STE
+$907K

Sector Composition

Rank Sector Weight
1 Financials 28.16%
2 Healthcare 18.37%
3 Technology 14.33%
4 Industrials 8.16%
5 Consumer Discretionary 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLAD icon
176
Gladstone Capital
GLAD
$430M
$615K 0.29%
25,581
-8,027
-24% -$187K
ADMA icon
177
ADMA Biologics
ADMA
$1.97B
$611K 0.29%
30,552
– –
BXSL icon
178
Blackstone Secured Lending
BXSL
$5.35B
$579K 0.27%
19,758
-1,476
-7% -$44.6K
BSL
179
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$169M
$566K 0.26%
40,116
-11,353
-22% -$161K
ALNY icon
180
Alnylam Pharmaceuticals
ALNY
$37.2B
$566K 0.26%
2,058
– –
PHAT icon
181
Phathom Pharmaceuticals
PHAT
$953M
$544K 0.25%
30,078
– –
SMCI icon
182
Super Micro Computer
SMCI
$19.3B
$518K 0.24%
+12,430
New +$757K
MIRM icon
183
Mirum Pharmaceuticals
MIRM
$6.96B
$481K 0.23%
12,344
– –
MAIN icon
184
Main Street Capital
MAIN
$5B
$478K 0.22%
9,524
-2,596
-21% -$130K
OFS icon
185
OFS Capital
OFS
$46M
$469K 0.22%
55,560
+4,638
+9% +$39K
MRCC
186
DELISTED
Monroe Capital Corp
MRCC
$461K 0.22%
57,052
-9,696
-15% -$74.6K
TGTX icon
187
TG Therapeutics
TGTX
$8.53B
$460K 0.21%
19,651
– –
AUPH icon
188
Aurinia Pharmaceuticals
AUPH
$1.96B
$451K 0.21%
61,561
– –
ONC
189
BeOne Medicines Ltd
ONC
$33.8B
$444K 0.21%
1,979
– –
HRMY icon
190
Harmony Biosciences
HRMY
$2.08B
$443K 0.21%
11,067
– –
BCIC
191
BCP Investment Corp
BCIC
$88.1M
$442K 0.21%
23,821
-1,667
-7% -$31.7K
KNSA icon
192
Kiniksa Pharmaceuticals
KNSA
$4.89B
$439K 0.21%
17,556
– –
MPV
193
Barings Participation Investors
MPV
$171M
$437K 0.2%
+25,777
New +$419K
GILD icon
194
Gilead Sciences
GILD
$162B
$434K 0.2%
5,182
– –
DCF
195
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$431K 0.2%
46,906
-20,303
-30% -$183K
OXSQ icon
196
Oxford Square Capital
OXSQ
$148M
$427K 0.2%
150,728
-9,122
-6% -$26.9K
RARE icon
197
Ultragenyx Pharmaceutical
RARE
$2.65B
$424K 0.2%
7,638
– –
UTHR icon
198
United Therapeutics
UTHR
$26.3B
$410K 0.19%
1,145
– –
AXSM icon
199
Axsome Therapeutics
AXSM
$12.3B
$408K 0.19%
4,542
– –
BNTX icon
200
BioNTech
BNTX
$23B
$408K 0.19%
3,431
– –
6 7
8
9 10

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, Virtus ETF Advisers held 490 positions worth $214M, up 4.8% from $204M the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Virtus ETF Advisers's Q3 2024 filing shows 42 new, 186 increased, 165 reduced and 36 closed positions. Its largest new stake was OFS Credit Co: 278,579 shares worth $2.06M. The largest sale was Oxford Lane Capital, an estimated $1.49M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.

  • Virtus ETF Advisers's largest Q3 2024 buy was OFS Credit Co: 278,579 shares worth $2.06M.
  • Virtus ETF Advisers added most to Public Storage in Q3 2024, an estimated $927K increase.
  • Virtus ETF Advisers's biggest Q3 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.06M.
  • Virtus ETF Advisers fully exited Oxford Lane Capital in Q3 2024, selling an estimated $1.49M.
  • Virtus ETF Advisers's ten largest holdings make up 6.7% of its $214M portfolio in Q3 2024.
  • Virtus ETF Advisers opened 42 new positions and closed 36 in Q3 2024.
  • Virtus ETF Advisers's portfolio value rose 4.8% quarter-over-quarter to $214M.

Based on Virtus ETF Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.